Product Information

DEXTROAMP-AMPHET ER 15 MG CAP is a generic product labeled by Rhodes Pharmaceuticals L.P., priced at $0.5570 per EA under NDC 42858021501. Its NADAC has been published 358 times since Oct 16, 2019.

FDA first approved this application on May 17, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE, and AMPHETAMINE SULFATE market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for DEXTROAMP-AMPHET ER 15 MG CAP has been published 358 times since Oct 16, 2019, and over the history we have for it it has declined 69.7%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.